Literature DB >> 15053948

Erythropoietin and the nervous system.

Sermin Genc1, Tolga F Koroglu, Kursad Genc.   

Abstract

Erythropoietin (Epo) is a hematopoietic growth factor and cytokine which stimulates erythropoiesis. In recent years, Epo has been shown to have important nonhematopoietic functions in the nervous system. Nonerythropoietic actions of Epo include a critical role in the development, maintenance, protection and repair of the nervous system. A wide variety of experimental studies have shown that Epo and its receptor are expressed in the nervous system and Epo exerts remarkable neuroprotection in cell culture and animal models of nervous system disorders. In this review, we summarize the current knowledge on the neurotrophic and neuroprotective properties of Epo, the mechanisms by which Epo produces neuroprotection and the signal transduction systems regulated by Epo in the nervous system.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15053948     DOI: 10.1016/j.brainres.2003.12.037

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  39 in total

1.  Erythropoietin: still on the neuroprotection road.

Authors:  Nelvys Subirós; Diana García Del Barco; Rosa M Coro-Antich
Journal:  Ther Adv Neurol Disord       Date:  2012-05       Impact factor: 6.570

Review 2.  The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury.

Authors:  Z Z Chong; K Maiese
Journal:  Histol Histopathol       Date:  2007-11       Impact factor: 2.303

Review 3.  Erythropoietic agents and the elderly.

Authors:  Neeraj Agarwal; Josef T Prchal
Journal:  Semin Hematol       Date:  2008-10       Impact factor: 3.851

Review 4.  Iron-chelating backbone coupled with monoamine oxidase inhibitory moiety as novel pluripotential therapeutic agents for Alzheimer's disease: a tribute to Moussa Youdim.

Authors:  Orly Weinreb; Silvia Mandel; Orit Bar-Am; Tamar Amit
Journal:  J Neural Transm (Vienna)       Date:  2011-03-01       Impact factor: 3.575

Review 5.  The Potential Roles of Aquaporin 4 in Alzheimer's Disease.

Authors:  Yu-Long Lan; Jie Zhao; Tonghui Ma; Shao Li
Journal:  Mol Neurobiol       Date:  2015-10-03       Impact factor: 5.590

6.  Cerebral arteriovenous malformation presenting with polycythemia vera: A case report and literature review.

Authors:  Mairaj T Sami; Bradley N Bohnstedt; Eyas M Hattab; Raymond Markham; Aaron A Cohen-Gadol
Journal:  Int J Surg Case Rep       Date:  2013-07-20

7.  Otoprotective effects of erythropoietin on Cdh23erl/erl mice.

Authors:  F Han; H Yu; T Zheng; X Ma; X Zhao; P Li; L Le; Y Su; Q Y Zheng
Journal:  Neuroscience       Date:  2013-02-04       Impact factor: 3.590

8.  Gene expression profiling in equine polysaccharide storage myopathy revealed inflammation, glycogenesis inhibition, hypoxia and mitochondrial dysfunctions.

Authors:  Eric Barrey; Elodie Mucher; Nicolas Jeansoule; Thibaut Larcher; Lydie Guigand; Bérénice Herszberg; Stéphane Chaffaux; Gérard Guérin; Xavier Mata; Philippe Benech; Marielle Canale; Olivier Alibert; Péguy Maltere; Xavier Gidrol
Journal:  BMC Vet Res       Date:  2009-08-07       Impact factor: 2.741

9.  The role of erythropoietin in remote renal preconditioning on hippocampus ischemia/reperfusion injury.

Authors:  Mehdi Khaksari; Fatemeh Zare Mehrjerdi; Mohammad Ebrahim Rezvani; Fatemeh Safari; Aghdas Mirgalili; Somayeh Niknazar
Journal:  J Physiol Sci       Date:  2016-04-20       Impact factor: 2.781

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.